BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 17655931)

  • 1. Immunosuppressive therapy for ocular mucous membrane pemphigoid strategies and outcomes.
    Saw VP; Dart JK; Rauz S; Ramsay A; Bunce C; Xing W; Maddison PG; Phillips M
    Ophthalmology; 2008 Feb; 115(2):253-261.e1. PubMed ID: 17655931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular cicatricial pemphigoid.
    Tauber J
    Ophthalmology; 2008 Sep; 115(9):1639-40; author reply 1640-1. PubMed ID: 18762085
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy.
    Thorne JE; Woreta FA; Jabs DA; Anhalt GJ
    Ophthalmology; 2008 Dec; 115(12):2146-2152.e1. PubMed ID: 18930554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ocular Cicatricial Pemphigoid - a Retrospective Study].
    Szabó E; Palos M; Skalická P
    Cesk Slov Oftalmol; 2016 Feb; 72(1):283-92. PubMed ID: 27041284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycophenolate mofetil therapy for inflammatory eye disease.
    Thorne JE; Jabs DA; Qazi FA; Nguyen QD; Kempen JH; Dunn JP
    Ophthalmology; 2005 Aug; 112(8):1472-7. PubMed ID: 16061096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of therapy with mycophenolate mofetil in ocular mucous membrane pemphigoid.
    Doycheva D; Deuter C; Blumenstock G; Stuebiger N; Zierhut M
    Ocul Immunol Inflamm; 2011 Dec; 19(6):431-8. PubMed ID: 22106912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of mucous membrane pemphigoid with mycophenolate mofetil.
    Nottage JM; Hammersmith KM; Murchison AP; Felipe AF; Penne R; Raber I
    Cornea; 2013 Jun; 32(6):810-5. PubMed ID: 23132447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid.
    Miserocchi E; Baltatzis S; Roque MR; Ahmed AR; Foster CS
    Ophthalmology; 2002 Jan; 109(1):111-8. PubMed ID: 11772589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Early clinical results with mycophenolate mofetil in immunosuppressive therapy of ocular pemphigoid].
    Zurdel J; Aboalchamat B; Zierhut M; Stübiger N; Bialasiewicz A; Engelmann K
    Klin Monbl Augenheilkd; 2001 Apr; 218(4):222-8. PubMed ID: 11392266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of mucous membrane pemphigoid with ocular involvement in young patients.
    Rauz S; Maddison PG; Dart JK
    Ophthalmology; 2005 Jul; 112(7):1268-74. PubMed ID: 15921743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on ocular cicatricial pemphigoid and emerging treatments.
    Queisi MM; Zein M; Lamba N; Meese H; Foster CS
    Surv Ophthalmol; 2016; 61(3):314-7. PubMed ID: 26708362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of patients with confirmed and presumed mucous membrane pemphigoid undergoing entropion repair.
    Gibbons A; Johnson TE; Wester ST; Gonzalez AE; Farias CC; Betancurt C; Amescua G; Perez VL
    Am J Ophthalmol; 2015 May; 159(5):846-52.e2. PubMed ID: 25644537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methotrexate therapy for ocular cicatricial pemphigoid.
    McCluskey P; Chang JH; Singh R; Wakefield D
    Ophthalmology; 2004 Apr; 111(4):796-801. PubMed ID: 15051215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current medical treatment of ocular mucous membrane pemphigoid.
    Sobolewska B; Deuter C; Zierhut M
    Ocul Surf; 2013 Oct; 11(4):259-66. PubMed ID: 24112229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of mucous membrane pemphigoid with the combination of mycophenolate mofetil, dapsone, and prednisolone: a case series.
    Staines K; Hampton PJ
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Jul; 114(1):e49-56. PubMed ID: 22727107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies.
    Letko E; Miserocchi E; Daoud YJ; Christen W; Foster CS; Ahmed AR
    Clin Immunol; 2004 Jun; 111(3):303-10. PubMed ID: 15183151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ocular cicatricial pemphigoid. Retrospective analysis of risk factors and complications].
    Messmer EM; Hintschich CR; Partscht K; Messer G; Kampik A
    Ophthalmologe; 2000 Feb; 97(2):113-20. PubMed ID: 10734737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostics and pharmacological treatment of ocular cicatrical pemphigoid].
    Brydak-Godowska J; Moneta-Wielgoś J; Pauk-Domańska M; Dróbecka-Brydak E; Samsel A; Kecik M; Kowalewski C; Mackiewicz W; Kecik D
    Klin Oczna; 2005; 107(10-12):725-7. PubMed ID: 16619831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of a novel protocol of pulsed intravenous cyclophosphamide for recalcitrant or severe ocular inflammatory disease.
    Suelves AM; Arcinue CA; González-Martín JM; Kruh JN; Foster CS
    Ophthalmology; 2013 Jun; 120(6):1201-9. PubMed ID: 23601800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycophenolate mofetil for ocular inflammation.
    Daniel E; Thorne JE; Newcomb CW; Pujari SS; Kaçmaz RO; Levy-Clarke GA; Nussenblatt RB; Rosenbaum JT; Suhler EB; Foster CS; Jabs DA; Kempen JH
    Am J Ophthalmol; 2010 Mar; 149(3):423-32.e1-2. PubMed ID: 20042178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.